Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
18.63
-0.05 (-0.27%)
Jan 21, 2025, 4:00 PM EST - Market closed
Embecta Employees
Embecta had 2,100 employees as of September 30, 2024. The number of employees decreased by 100 or -4.55% compared to the previous year.
Employees
2,100
Change (1Y)
-100
Growth (1Y)
-4.55%
Revenue / Employee
$534,810
Profits / Employee
$37,286
Market Cap
1.08B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 2,100 | -100 | -4.55% |
Sep 30, 2023 | 2,200 | 300 | 15.79% |
Sep 30, 2022 | 1,900 | -129 | -6.36% |
Sep 30, 2021 | 2,029 | -298 | -12.81% |
Sep 30, 2020 | 2,327 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
EMBC News
- 7 days ago - Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 4 weeks ago - embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - New Initiatives Expected To Make Embecta More Profitable - Seeking Alpha
- 2 months ago - Embecta Corp. (EMBC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps - Benzinga
- 2 months ago - Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs - GlobeNewsWire
- 2 months ago - embecta Announces Quarterly Cash Dividend - GlobeNewsWire
- 2 months ago - UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire